跳至主要内容
临床试验/JPRN-UMIN000005331
JPRN-UMIN000005331已完成4 期

Comparison of the effect on vascular endothelial function and systemic metabolism between Liraglutide and insulin Glargine in patients with type 2 diabetes -prospective randomized controlled trial- - Study for the effects of Liraglutide on vascular endothelial function and systemic metabolism in patients with type 2 diabetes

Hokkaido University Hospital0 个研究点目标入组 30 人开始时间: 2011年3月28日最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) patients who received insulin injection therapy, 2) severe hepatic dysfunction, renal dysfunction, heart failure, 3) history of angina, myocardial infarction, stroke or other arteriosclerotic diseases, 4) patients who receive more than three antihypertensive agents, 5) patients who receive more than two antidyslipidemia agents, 6) history of anaphylaxis of liragrutide or insulin glargine, 7) pregnancy, 8) patients who are inadequate to enter this study due to the other reasons by physician's judgments

研究者

相似试验